Halloum, Wael
Dughem, Yousef Al
Beier, Dagmar
Pellesi, Lanfranco
Article History
Received: 17 June 2024
Accepted: 3 July 2024
First Online: 12 July 2024
Declarations
:
: Not applicable.
: Not applicable.
: DB received presentation fees (TEVA, Novartis and Pfizer), travel fees (Allergan, TEVA, Pfizer, Abbvie and Lundbeck), advisory board fees (Novartis, Lilly, Teva, Lundbeck, Pfizer and Abbvie) and participated in clinical trials (TEVA, Lundbeck, Novartis, Lilly and Novo Nordisk Foundation) outside of the submitted work. LP has been employed by Lundbeck in the past two years. WH and YAD declare that they have no competing interests.